Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 14, Issue 5

Abstract

Background: Transcatheter arterial chemoembolization (TACE) refractoriness is an indication for sorafenib treatment in patients with intermediate-stage hepatocellular carcinoma (HCC). This study aims at evaluating the efficacy of conversion of treatment to sorafenib on overall survival (OS) among trans arterial chemoembolization (TACE)-refractory HCC patients. Methods: This retrospective cohort study included 497 patients with HCC treated with TACE between January 2008 and December 2013 at the Kindai University Hospital. Among those patients, 56 were considered refractory to TACE. These TACE-refractory patients were grouped into two cohorts: a) patients who switched treatment from TACE to sorafenib (sorafenib group) and b) those who continued TACE (TACE group). We evaluated the OS of patients from the initial TACE.Results: Thirty-two patients were classified into the sorafenib group, while 24 patients were in the TACE group. The median OS from the initial TACE was 4.29 years in the sorafenib group and 2.14 years in the TACE group (p < 0.0010).Conclusion: Conversion of treatment to sorafenib might improve the OS in TACE-refractory patients with intermediate-stage HCC. Hence, conversion of treatment should be considered for HCC patients refractory to TACE.

Authors and Affiliations

Tadaaki Arizumic, Tomohiro Minami, Masatoshi Kudo

Keywords

Related Articles

Is Drainage of Abdominal Cavity Necessary After Laparoscopic Appendectomy?

Acute appendicitis is one of the most common causes of acute abdominal pain and is one of the most common surgical abdominal emergencies. Nowadays, patients with acute appendicitis are managed in most cases with laparosc...

Oils for Skin Therapy for Suffering Seniors

Owing to aging, many senior citizens experience skin dryness which manifests as itchy skin. The itchy skin can appear suddenly without notice, and the taken-by-surprise senior may not realize what the cause of it could b...

Conformational Changes of Vitamin D Receptor as a Potential Cause of Multiple Sclerosis

Multiple sclerosis (MS) is an autoimmune inflammatory disorder of unknown etiology affecting central nervous system (CNS)characterized by demyelination and variable degrees of axonal loss [1]. The etiology of MS is still...

Cortical Activity Changes after Art Making and Rote Motor Movement as Measured by EEG: A Preliminary Study

This preliminary quantitative EEG study explores the differences in cortical activation patterns of subjects immediately following art making and following rote motor tasks of coin tossing and pencil rotation. It is hypo...

Correlation of Reduced Glutathione with Brest Cancer Using High Performance Liquid Chromatography

Cancer is a group of diseases that cause cells in the body to change and grow out of control. Most types of cancer cells eventually form a lump or mass called a tumor, and are named after the part of the body where the t...

Download PDF file
  • EP ID EP585992
  • DOI 10.26717/BJSTR.2019.14.002610
  • Views 176
  • Downloads 0

How To Cite

Tadaaki Arizumic, Tomohiro Minami, Masatoshi Kudo (2019). Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization. Biomedical Journal of Scientific & Technical Research (BJSTR), 14(5), 10906-10910. https://www.europub.co.uk/articles/-A-585992